Delivery Order SPE2DB20D1102-SPE2DB25FC5YH
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568436585 - VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product, with a ceiling value of $56,898.10 and a completion date of June 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This federal contract award, identified as SPE2DB22D3010|SPE2DB25FP2CC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, with a ceiling value of $5,314.65 and an ultimate completion date of April 7, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug...
This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD8FC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,893.79 fixed-price delivery order is for the pharmaceutical product VALSARTAN-HCTZ 320-12.5 MG TAB 90S, to be delivered by June 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with identification number SPE2DB20D3101|SPE2DB24FQYS3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $3,591.83 for the provision of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2024 and utilizes a Firm Fixed Price pricing type. It is not designated with any...
This contract award, with ID SPE2DB20D3303|SPE2DB25FZ4E1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.24, is for the delivery of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.42, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen...
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FR84Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets, with an ultimate completion date of January 2, 2024 and a ceiling value of $2,150.51. The contract is a delivery order, with a firm fixed price pricing type. It is not designated with a set-aside...
This federal contract award, valued at $40,348.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of 4566177345 - Valsartan-HCTZ 320-25 mg tablets in 90-count packages. This is a firm-fixed-price delivery order contract with an ultimate completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,912.99, is for the delivery of 4567626817 VALSARTAN-HCTZ 320-25 MG TAB 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product, with a ceiling value of $8,594.99. The contract is a firm fixed price Delivery Order with a period of performance extending through May 20, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...